UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062296
Receipt number R000071240
Scientific Title Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial
Date of disclosure of the study information 2026/07/25
Last modified on 2026/07/24 14:45:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial

Acronym

Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial

Scientific Title

Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial

Scientific Title:Acronym

Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial

Region

Japan


Condition

Condition

knee osteoarthritis

Classification by specialty

Orthopedics Anesthesiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to test the hypothesis that adding the vastus intermedius (NVI) nerve and the vastus lateralis (NVL) nerve blocks to a femoral triangle block (FTB) combined with an IPACK block improves postoperative pain scores in patients undergoing total knee arthroplasty (TKA).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative pain Numerical Rating Scale (NRS) scores

Key secondary outcomes

Pain NRS score
Pain location
Motor assessment
Opioid consumption
Knee functional assessment
Quality of recovery
Consumption of postoperative additional analgesics
Complications and adverse events
Blinding Assessment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Addition of vastus intermedius and vastus lateralis nerve blocks (5 mL of 0.25% levobupivacaine each)

Interventions/Control_2

No additional vastus intermedius and vastus lateralis nerve blocks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Participants aged between 18 and 85 years
2. Participants were scheduled for primary unilateral TKA for osteoarthritis
3. American Society of Anaesthesiologists Physical Status Classification I-III
4. Body mass index of 18-40 kg/m2
5. Written informed consent is provided

Key exclusion criteria

1. Allergy to any drug administered in this study
2. Pre-existing lower limb motor dysfunction
3. Severe hepatic or renal dysfunction
4. Uncontrolled asthma
5. Inability to reliably assess pain
6. Severe peripheral neuropathy
7. Anticipated technical difficulty in performing the nerve blocks
8. Inability or unwillingness to comply with the study protocol
9. Chronic opioid use

Target sample size

74


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Fujino

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

+81-3-3813-3111

Email

t-fujino@juntendo.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Fujino

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

+81-3-3813-3111

Homepage URL


Email

t-fujino@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Juntendo University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee Faculty Of Medicine, Juntendo University

Address

3-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

+81-3-5802-1584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院


Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 06 Month 07 Day

Date of IRB

2026 Year 07 Month 13 Day

Anticipated trial start date

2026 Year 08 Month 12 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 22 Day

Last modified on

2026 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071240